Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $124.04 USD
Change Today +1.00 / 0.81%
Volume 4.6M
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Hugin MBA

Chairman, Chief Executive Officer and Chairman of Executive Committee,Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 47 board members in 5 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Robert J. Hugin, also known as Bob, MBA has been the Chief Executive Officer of Celgene Corporation since June 16, 2010. Mr. Hugin served as the President of Celgene Corporation since May 1, 2006 until August 1, 2014. He served as Secretary of Celgene Corporation and served as its Chief Financial Officer from June 1999 to May 1, 2006, Chief Operating Officer from May 1, 2006 to June 16, 2010 and as its Senior Vice President from June 1999 to May 1, 2006. At Celgene ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: --

Board Members Memberships*

Chairman, Chief Executive Officer and Chairman of Executive Committee
Independent Director and Member of Compensation Committee
Director and Member of Audit Committee


BA 1976
Princeton University
MBA 1985
University of Virginia

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,380,000

Stock Options*

Restricted Stock Awards$3,899,980
All Other Compensation$231,416
Exercised Options934,808
Exercised Options Value$81,182,157
Exercisable Options1,474,372
Unexercisable Options970,128
Total Value of Options$81,182,157
Total Number of Options3,379,308

Total Compensation*

Total Annual Cash Compensation$10,721,685
Total Short Term Compensation$1,380,000
Other Long Term Compensation$4,131,396
Total Calculated Compensation$24,236,113
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $124.04 USD +1.00


Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at